Dabur Q4 PAT up 15% to Rs 369 crore; declares Rs 5.50 dividend amid Africa push
Dabur reported Q4 PAT up 15% YoY to Rs 369 crore on 7% revenue growth, alongside a Rs 5.50 per share dividend. The FMCG major is scaling Africa operations with peers GCPL, VBL and Marico, while navigating a US FDA data-integrity flag and post-GST-cut price revisions.
What happened
Dabur India · Indian FMCG firms including Dabur, GCPL, VBL and Marico are scaling Africa operations. Dabur faced a US FDA data-integrity flag, revised prices
Key facts
- PAT Rs 369 crore
- PAT up 15% YoY
- revenue up 7%
- dividend Rs 5.50 per share
Why this matters
Dabur's Africa expansion alongside GCPL, VBL and Marico marks an active geographic diversification play worth tracking for partnership, distribution, or bolt-on acquisition opportunities in emerging FMCG markets.
What to watch
- FDA Form 483 follow-up or warning letter conversion
- Q1 volume growth print vs price-led growth split
- Rural demand recovery indicators and monsoon outlook
- Africa revenue contribution disclosure in segment reporting
- Input cost (palm oil, packaging) inflation trends
- Monitor management commentary on Africa unit economics and capex allocation
- Track FDA remediation timeline and any import-alert disclosures
- Watch peer reads from GCPL, Marico, VBL on Africa traction and FMCG demand
- Assess gross margin trajectory post-GST price revisions in next quarter guidance